The price of Zevia PBC (NYSE:ZVIA) shares last traded on Wall Street fell -1.41% to $2.79.
ZVIA stock price is now 17.81% away from the 50-day moving average and 21.46% away from the 200-day moving average. The market capitalization of the company currently stands at $207.08M.
With the price target reduced from $5 to $4, Telsey Advisory Group Downgraded its rating from Outperform to Market Perform for Zevia PBC (NYSE: ZVIA). On July 25, 2023, Goldman Downgraded its previous ‘Buy’ rating to ‘Neutral’ on the stock reducing its target price from $5 to quote $3
In other news, Spence Padraic L., Director sold 75,000 shares of the company’s stock on May 12 ’25. The stock was sold for $203,265 at an average price of $2.71. Upon completion of the transaction, the Director now directly owns 1,760,695 shares in the company, valued at $4.91 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 12 ’25, Director Spence Padraic L. bought 75,000 shares of the business’s stock. A total of $203,262 was incurred on buying the stock at an average price of $2.71. A total of 30.07% of the company’s stock is owned by insiders.
During the past 12 months, Zevia PBC has had a low of $0.62 and a high of $4.99. As of last week, the company has a debt-to-equity ratio of 0.02, a current ratio of 2.34, and a quick ratio of 1.63.
The net profit margin was -12.54% and return on equity was -28.87% for ZVIA. The company reported revenue of $38.02 million for the quarter, compared to $38.8 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -2.0 percent. For the current quarter, analysts expect ZVIA to generate $41.63M in revenue.
